RCPA is pleased to announce that Gaudenzia CEO Dale Klatzker has been appointed to the Behavioral Health Commission for Adult Mental Health.
The commission was created in the recently passed fiscal code as part of Pennsylvania’s fiscal year 2022/23 budget. Language in the law specifically directed the commission to include as a member, among others, “A recognized subject matter expert in the treatment of co-occurring mental health and substance use disorders from a list of recommendations compiled by the Rehabilitation and Community Providers Association with experience in behavioral health matters.” Gov. Wolf selected Klatzker from among a list of RCPA member behavioral health experts provided by the association.
A leader in behavioral health care for more than 35 years, Klatzker was appointed CEO of Gaudenzia, Inc. in March 2019. Gaudenzia operates substance use disorder (SUD) and co-occurring mental health (MH) programs in Pennsylvania, Maryland, Delaware, and Washington, D.C. Established in Philadelphia in 1968, Gaudenzia, Inc. is Pennsylvania’s largest non-profit provider of treatment for SUD and co-occurring disorders.
Before joining Gaudenzia, Klatzker held roles as senior consultant and chief clinical officer for The Margolin Group, as well as senior vice president, Population Health Management, for Care New England. Previous to those roles, he was president and CEO of The Providence Center (TPC) and was at the forefront of establishing programs that integrate primary and behavioral health care through community partnerships and strategic consumer-focused programming. Through his leadership, TPC became a national model for integrated care in community mental health settings.
Klatzker has been both locally and nationally recognized for his leadership and innovative contributions to the field. He has served as board chair of the National Council for Community Behavioral Healthcare, chair of Mental Health Corporations of America, fellow for the Rhode Island Foundation Fellows Program, associate clinical professor at Alpert Medical School at Brown University, adjunct professor of psychology at Johnson and Wales University, and adjunct assistant professor at the Department of Social Sciences and Education at Colby-Sawyer College. He also served on the Rhode Island Healthcare Reform Commission, Community Healthcare Providers Leadership Council, and numerous other commissions and committees. He received his PhD from the Brandeis University Heller School and his MSW from Boston University.
Reporting to the Department of Human Services, the commission is to be comprised of 24 individuals from various state agencies or areas of specialty, as well as legislative appointees. The commission is charged with issuing a report of recommended funding allocations to the following areas. This funding will come from $100 million of federal American Rescue Plan funds.
Today, the Department of Drug and Alcohol Programs (DDAP) was joined by national nonprofit Shatterproof and substance use disorder treatment provider Gaudenzia to announce the expansion of the free and confidential Addiction Treatment Locator, Assessment, and Standards Platform (ATLAS) to Pennsylvania.
ATLAS evaluates addiction treatment facilities’ use of evidence-based best practices based on the Shatterproof National Principles of Care, includes an assessment to understand the appropriate level of care, and offers an easy-to-use dashboard to allow those in need and their loved ones to search for and compare facilities using criteria such as location, services offered, and insurance accepted so they can find the best treatment for their unique needs. ATLAS is fully available in English and Spanish.
“We are grateful for ATLAS and the team at Shatterproof for making the submission process so easy,” said Dr. Dale Klatzker, President and CEO at Gaudenzia, Inc. “It is vital that we reduce barriers to treatment, and this tool provides an easy way for those in need to seek and quickly find a treatment option that will work best for them.”
Forty Gaudenzia treatment locations and a total of 515 substance use disorder treatment facilities across the state have submitted their information to be included in ATLAS. An additional open enrollment period for facilities who missed the first deadline will be available in fall 2022.